| Utestående aktier | 26,179,302 shares |
| Insideraktier | 1 781 700 shares |
| Insynsägande | 6,81 % |
| Totalt antal insynspersoner | 31 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
903 out of 11218Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Anthera Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Eric Buatois
10% Owner -
|
44 969 | 5 621 | |
| Bogdan Dziurzynski Director - [D] | 10 000 | 1 250 | |
| Klara Dickinson SVP & Chief Regulatory Office - [O] | 12 500 | 1 562 | |
| Steven B Engle | 41 379 | ||
| Ursula Fritsch VP, Glob. Reg. and Compliance - [O] | 55 592 | 6 949 | |
| Brent Furse | 84 705 | ||
| James Healy Director - [D] | 32 443 | 4 055 | |
| Christopher S Henney Director - [D] | 100 000 | 12 500 | |
| Colin Hislop Chief Medical Officer - [O] | 19 147 | 2 393 | |
| Samuel D Isaly Director - [D] | 7 462 000 | 932 750 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Georgina Kilfoil SVP,Product Dev.& Project Mgmt - [O] | 30 035 | 3 754 | |
| May Liu SVP, Finance & Administration - [O] | 32 302 | 4 038 | |
| Lowe Christopher P. CFO and Chief Business Officer - [O] | 108 915 | 13 614 | |
| Mark Drew McManigle | 0 | ||
| Brian Mueller Director - [D] | 10 000 | 1 250 | |
| Debra Odink Chief Technology Officer - [O] | 7 896 | 987 | |
| Orbimed Advisors Llc Director - [D] | 7 462 000 | 932 750 | |
| Charles V Olson CHIEF TECHNOLOGY OFFICER - [O] | 17 519 | 2 190 | |
| James E Pennington Chief Medical Officer & Ex. VP - [O] | 105 140 | 13 142 | |
| James Pennington Interim Chief Medical Officer - [O] | 35 376 | 4 422 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| William R Jr Shanahan | 567 876 | ||
|
Sofinnova Venture Partners Vi L P
10% Owner -
|
44 969 | 5 621 | |
| Daniel K Spiegelman | 12 500 | ||
| Philip Sager | 84 705 | ||
| John Craig Thompson President & CEO, Director - [D] [O] | 19 848 | 19 848 | |
| Paul F Truex Director - [D] | 16 793 | 16 793 | |
| Thompson David E. Director - [D] | 128 201 | 16 025 | |
| Thompson Peter A. | 12 000 | ||
| Joaquim Trias SR VP, Preclinical Development - [O] | 156 643 | 19 580 | |
| Sanford S Zweifach | 28 846 | ||
|
Zenyaku Kogyo Co., Ltd.
10% Owner -
|
5 591 790 | 698 974 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i ANTH / Anthera Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i ANTH / Anthera Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-01-09 | 2018-01-05 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Furse Brent | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Furse Brent | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Mueller Brian | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Mueller Brian | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Sager Philip | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Sager Philip | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | TRUEX PAUL F | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | TRUEX PAUL F | ANTH | Stock Option (right to buy) | D | 1,65 | 84 705 | 84 705 | |||||
| 2018-01-09 | 2018-01-05 | 4 | LIU MAY | ANTH | Stock Option (right to buy) | D | 1,65 | 427 066 | 427 066 | |||||
| 2018-01-09 | 2018-01-05 | 4 | SHANAHAN WILLIAM R JR | ANTH | Stock Option (right to buy) | D | 1,65 | 567 876 | 567 876 | |||||
| 2018-01-09 | 2018-01-05 | 4 | THOMPSON JOHN CRAIG | ANTH | Stock Option (right to buy) | D | 1,65 | 1 847 074 | 1 847 074 | |||||
| 2017-09-20 | 2017-09-20 | 4 | THOMPSON JOHN CRAIG | ANTH | Common stock | D | 1,3200 | 8 550 | 11 | 19 848 | ||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 24,16 | −10 000 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 28,16 | −10 000 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 22,88 | −926 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 75,94 | −3 750 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 75,84 | −5 000 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 12,88 | −15 000 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 26,40 | −843 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 39,04 | −10 938 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 96,64 | −9 | 0 | |||||
| 2017-09-15 | 2017-09-15 | 4 | LIU MAY | ANTH | Stock Option (right to buy) | D | 96,64 | −365 | 0 | |||||
| 2017-09-07 | 2017-09-07 | 4/A | THOMPSON JOHN CRAIG | ANTH | Common stock | D | 1,4320 | 10 400 | 15 | 11 298 | ||||
| 2017-09-07 | 2017-09-07 | 4 | TRUEX PAUL F By Trust | ANTH | Common Stock | I | 1,3400 | 5 000 | 7 | 16 793 | ||||
| 2017-09-07 | 2017-09-07 | 4 | THOMPSON JOHN CRAIG | ANTH | Common stock | D | 1,4320 | 10 400 | 15 | 17 590 | ||||
| 2017-05-22 | 2017-05-20 | 4 | Dickinson Klara | ANTH | Stock option (right to buy) | D | 1,63 | 43 750 | 43 750 | |||||
| 2017-05-22 | 2017-05-20 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 1,63 | 53 125 | 53 125 | |||||
| 2017-05-22 | 2017-05-20 | 4 | THOMPSON JOHN CRAIG | ANTH | Stock option (right to buy) | D | 1,63 | 81 250 | 81 250 | |||||
| 2017-05-22 | 2017-05-20 | 4 | Olson Charles V | ANTH | Stock option (right to buy) | D | 1,63 | 43 750 | 43 750 | |||||
| 2017-05-22 | 2017-05-20 | 4 | SHANAHAN WILLIAM R JR | ANTH | Stock option (right to buy) | D | 1,63 | 75 000 | 75 000 | |||||
| 2017-05-19 | 2017-05-19 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 39,04 | −84 376 | 0 | |||||
| 2017-05-19 | 2017-05-19 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 96,64 | −1 369 | 0 | |||||
| 2017-03-03 | 2016-12-06 | 4/A | THOMPSON JOHN CRAIG | ANTH | Stock option (right to buy) | D | 1,47 | 200 000 | 200 000 | |||||
| 2017-03-03 | 2017-03-03 | 4 | THOMPSON JOHN CRAIG | ANTH | Stock option (right to buy) | D | 0,64 | 100 000 | 100 000 | |||||
| 2017-02-06 | 2017-01-11 | 5 | Olson Charles V | ANTH | Common Stock | D | 0,5500 | 7 767 | 4 | 17 519 | ||||
| 2017-02-06 | 2016-06-30 | 5 | Olson Charles V | ANTH | Common Stock | D | 2,6300 | 1 789 | 5 | 9 752 | ||||
| 2017-02-06 | 2017-01-11 | 5 | THOMPSON JOHN CRAIG | ANTH | Common Stock | D | 0,5500 | 7 190 | 4 | 7 190 | ||||
| 2016-12-08 | 2016-12-08 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 2,00 | 83 910 | 83 910 | |||||
| 2016-12-08 | 2016-12-08 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 2,00 | 83 910 | 83 910 | |||||
| 2016-12-06 | 2016-12-02 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 9,48 | −180 000 | 0 | |||||
| 2016-12-06 | 2016-12-02 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 9,48 | −170 000 | 0 | |||||
| 2016-12-06 | 2016-12-06 | 4 | THOMPSON JOHN CRAIG | ANTH | Stock option (right to buy) | D | 1,47 | 300 000 | 300 000 | |||||
| 2016-09-22 | 2016-09-20 | 4 | TRUEX PAUL F By Trust | ANTH | Common stock | I | 5 008 | 94 345 | ||||||
| 2016-09-22 | 2016-09-20 | 4 | TRUEX PAUL F | ANTH | Common stock | D | −5 008 | 0 | ||||||
| 2016-09-22 | 2016-09-20 | 4 | TRUEX PAUL F | ANTH | Common stock | D | 2,0800 | 5 008 | 10 | 5 008 | ||||
| 2016-09-22 | 2007-01-23 | 4 | TRUEX PAUL F | ANTH | Stock Option (right to buy) | D | 2,08 | −5 008 | 25 845 | |||||
| 2016-06-13 | 2016-06-09 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 3,52 | 300 000 | 300 000 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Dickinson Klara | ANTH | Stock option (right to buy) | D | 3,52 | 105 000 | 105 000 | |||||
| 2016-06-13 | 2016-06-09 | 4 | THOMPSON JOHN CRAIG | ANTH | Stock option (right to buy) | D | 3,52 | 170 000 | 170 000 | |||||
| 2016-06-13 | 2016-06-09 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 3,52 | 80 000 | 80 000 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Olson Charles V | ANTH | Stock option (right to buy) | D | 3,52 | 100 000 | 100 000 | |||||
| 2016-04-29 | 2016-04-27 | 4 | ENGLE STEVEN B | ANTH | Stock Option (right to buy) | D | 3,80 | 41 379 | 41 379 | |||||
| 2016-04-29 | 2016-04-27 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 3,80 | 62 069 | 62 069 | |||||
| 2016-04-29 | 2016-04-27 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 3,80 | 41 379 | 41 379 | |||||
| 2016-04-29 | 2016-04-27 | 4 | Mueller Brian | ANTH | Stock Option (right to buy) | D | 3,80 | 41 379 | 41 379 | |||||
| 2016-04-29 | 2016-04-27 | 4 | Sager Philip | ANTH | Stock Option (right to buy) | D | 3,80 | 41 379 | 41 379 | |||||
| 2016-04-05 | 3 | Pennington James | ANTH | Common Stock | D | 35 376 | ||||||||
| 2016-04-05 | 3 | Pennington James | ANTH | Common Stock | D | 35 376 | ||||||||
| 2016-02-16 | 2016-02-12 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 2,86 | 15 816 | 15 816 | |||||
| 2016-02-16 | 2016-02-12 | 4 | Hislop Colin | ANTH | Stock Option (right to buy) | D | 2,86 | 10 848 | 10 848 | |||||
| 2016-02-16 | 2016-02-12 | 4 | Dickinson Klara | ANTH | Stock Option (right to buy) | D | 2,86 | 8 395 | 8 395 | |||||
| 2016-02-16 | 2016-02-12 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 2,86 | 7 407 | 7 407 | |||||
| 2016-02-16 | 2016-02-12 | 4 | Olson Charles V | ANTH | Stock option (right to buy) | D | 2,86 | 5 626 | 5 626 | |||||
| 2016-01-13 | 3 | Olson Charles V | ANTH | Common Stock | D | 15 926 | ||||||||
| 2016-01-13 | 3 | Olson Charles V | ANTH | Common Stock | D | 15 926 | ||||||||
| 2016-01-11 | 2015-06-30 | 5 | Dickinson Klara | ANTH | Common Stock | D | 1,4900 | 12 500 | 19 | 12 500 | ||||
| 2015-12-24 | 2015-12-23 | 4 | Mueller Brian | ANTH | Common stock | D | 2,8900 | 10 000 | 29 | 10 000 | ||||
| 2015-12-24 | 2014-07-29 | 4 | Mueller Brian | ANTH | Stock Option (right to buy) | D | 2,89 | −10 000 | 2 500 | |||||
| 2015-12-23 | 2015-06-30 | 5 | LIU MAY | ANTH | Common Stock | D | 1,4900 | 12 500 | 19 | 32 302 | ||||
| 2015-12-23 | 2015-06-30 | 5 | TRUEX PAUL F By Trust | ANTH | Common Stock | I | −12 500 | 89 337 | ||||||
| 2015-12-23 | 2015-06-30 | 5 | TRUEX PAUL F By Trust | ANTH | Common Stock | I | 12 500 | 101 837 | ||||||
| 2015-12-23 | 2015-06-30 | 5 | TRUEX PAUL F | ANTH | Common Stock | D | −12 500 | 0 | ||||||
| 2015-12-23 | 2015-06-30 | 5 | TRUEX PAUL F | ANTH | Common Stock | D | 1,4900 | 12 500 | 19 | 12 500 | ||||
| 2015-11-18 | 2015-11-13 | 4 | Hislop Colin | ANTH | Common Stock | D | 5,3073 | −12 500 | −66 | 19 147 | ||||
| 2015-11-18 | 2015-11-13 | 4 | Hislop Colin | ANTH | Common Stock | D | 1,6100 | 12 500 | 20 | 31 647 | ||||
| 2015-11-18 | 2014-12-30 | 4 | Hislop Colin | ANTH | Stock option | D | 1,61 | −12 500 | 107 500 | |||||
| 2015-11-12 | 2015-11-11 | 4 | Hislop Colin | ANTH | Common Stock | D | 5,3800 | −5 000 | −27 | 19 147 | ||||
| 2015-10-13 | 2015-10-12 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 6,1500 | −1 205 | −7 | 7 896 | ||||
| 2015-09-18 | 2015-09-17 | 4 | Dickinson Klara | ANTH | Stock option (right to buy) | D | 9,48 | 30 000 | 30 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | Dickinson Klara | ANTH | Stock option (right to buy) | D | 9,48 | 50 000 | 50 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 9,48 | 180 000 | 180 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 9,48 | 170 000 | 170 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 9,48 | 30 000 | 30 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 9,48 | 40 000 | 40 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | Hislop Colin | ANTH | Stock option (right to buy) | D | 9,48 | 30 000 | 30 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | Hislop Colin | ANTH | Stock option (right to buy) | D | 9,48 | 60 000 | 60 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | ODINK DEBRA | ANTH | Stock option (right to buy) | D | 9,48 | 30 000 | 30 000 | |||||
| 2015-09-18 | 2015-09-17 | 4 | ODINK DEBRA | ANTH | Stock option (right to buy) | D | 9,48 | 60 000 | 60 000 | |||||
| 2015-05-22 | 2015-05-21 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 4,75 | 43 269 | 43 269 | |||||
| 2015-05-22 | 2015-05-21 | 4 | ZWEIFACH SANFORD S | ANTH | Stock Option (right to buy) | D | 4,75 | 28 846 | 28 846 | |||||
| 2015-05-22 | 2015-05-21 | 4 | ENGLE STEVEN B | ANTH | Stock Option (right to buy) | D | 4,75 | 28 846 | 28 846 | |||||
| 2015-05-22 | 2015-05-21 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 4,75 | 28 846 | 28 846 | |||||
| 2015-05-22 | 2015-05-21 | 4 | Mueller Brian | ANTH | Stock Option (right to buy) | D | 4,75 | 28 846 | 28 846 | |||||
| 2015-05-22 | 2015-05-21 | 4 | Sager Philip | ANTH | Stock Option (right to buy) | D | 4,75 | 28 846 | 28 846 | |||||
| 2015-02-03 | 3 | Zenyaku Kogyo Co., Ltd. | ANTH | Common Stock | D | 5 591 790 | ||||||||
| 2015-02-03 | 3 | Zenyaku Kogyo Co., Ltd. | ANTH | Common Stock | D | 5 591 790 | ||||||||
| 2015-01-02 | 2014-12-30 | 4 | Sager Philip | ANTH | Stock Option (right to buy) | D | 1,61 | 15 000 | 12 500 | |||||
| 2015-01-02 | 2014-12-30 | 4 | Mueller Brian | ANTH | Stock Option (right to buy) | D | 1,61 | 12 500 | 12 500 | |||||
| 2015-01-02 | 2014-12-30 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 1,61 | 12 500 | 12 500 | |||||
| 2015-01-02 | 2014-12-30 | 4 | Hislop Colin | ANTH | Stock option (right to buy) | D | 1,61 | 120 000 | 120 000 | |||||
| 2015-01-02 | 2014-12-30 | 4 | ODINK DEBRA | ANTH | Stock option (right to buy) | D | 1,61 | 120 000 | 120 000 | |||||
| 2015-01-02 | 2014-12-30 | 4 | ODINK DEBRA By The Debra A. Odink Living Trust | ANTH | Common Stock | I | 1 364 | 13 855 | ||||||
| 2015-01-02 | 2014-12-30 | 4 | ODINK DEBRA | ANTH | Common Stock | D | −1 364 | 9 101 | ||||||
| 2015-01-02 | 2014-12-30 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 1,61 | 16 250 | 16 250 | |||||
| 2015-01-02 | 2014-12-30 | 4 | ENGLE STEVEN B | ANTH | Stock option (right to buy) | D | 1,61 | 12 500 | 12 500 | |||||
| 2015-01-02 | 2014-12-30 | 4 | ZWEIFACH SANFORD S | ANTH | Stock Option (right to buy) | D | 1,61 | 12 500 | 12 500 | |||||
| 2015-01-02 | 2014-12-31 | 4 | TRUEX PAUL F By Trust | ANTH | Common Stock | I | 12 500 | 89 337 | ||||||
| 2015-01-02 | 2014-12-31 | 4 | TRUEX PAUL F | ANTH | Common Stock | D | −12 500 | 0 | ||||||
| 2015-01-02 | 2014-12-30 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 1,61 | 330 000 | 330 000 | |||||
| 2015-01-02 | 2014-12-30 | 4 | LIU MAY | ANTH | Stock option (right to buy) | D | 1,61 | 120 000 | 120 000 | |||||
| 2014-08-04 | 2014-07-29 | 4 | Mueller Brian | ANTH | Stock Option (right to buy) | D | 2,89 | 12 500 | 12 500 | |||||
| 2014-08-04 | 2014-07-29 | 4 | Mueller Brian | ANTH | Stock Option (right to buy) | D | 2,89 | 18 750 | 18 750 | |||||
| 2014-07-01 | 2014-06-30 | 4 | TRUEX PAUL F By Trust | ANTH | Common Stock | I | −14 709 | 14 709 | ||||||
| 2014-07-01 | 2014-06-30 | 4 | TRUEX PAUL F By Trust | ANTH | Common Stock | I | −16 500 | 62 128 | ||||||
| 2014-07-01 | 2014-06-30 | 4 | TRUEX PAUL F | ANTH | Common Stock | D | 3,3900 | −699 | −2 | 14 709 | ||||
| 2014-07-01 | 2014-06-30 | 4 | TRUEX PAUL F | ANTH | Common Stock | D | 2,0800 | 2 000 | 4 | 13 845 | ||||
| 2014-06-16 | 2014-06-13 | 4 | ZWEIFACH SANFORD S | ANTH | Stock Option (right to buy) | D | 3,35 | 12 500 | 12 500 | |||||
| 2014-06-16 | 2014-06-13 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 3,35 | 15 625 | 15 625 | |||||
| 2014-06-16 | 2014-06-13 | 4 | ENGLE STEVEN B | ANTH | Stock option (right to buy) | D | 3,35 | 12 500 | 12 500 | |||||
| 2014-06-16 | 2014-06-13 | 4 | ENGLE STEVEN B | ANTH | Stock option (right to buy) | D | 3,35 | 18 750 | 18 750 | |||||
| 2014-06-16 | 2014-06-13 | 4 | SPIEGELMAN DANIEL K | ANTH | Stock Option (right to buy) | D | 3,35 | 12 500 | 12 500 | |||||
| 2014-06-16 | 2014-06-13 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 3,35 | 12 500 | 12 500 | |||||
| 2014-06-16 | 2014-06-13 | 4 | Sager Philip | ANTH | Stock Option (right to buy) | D | 3,35 | 12 500 | 31 250 | |||||
| 2014-06-16 | 2014-06-13 | 4 | Sager Philip | ANTH | Stock Option (right to buy) | D | 3,35 | 18 750 | 18 750 | |||||
| 2014-03-28 | 2014-03-25 | 4/A | TRUEX PAUL F | ANTH | Stock option (right to buy | D | 3,30 | 18 440 | 18 440 | |||||
| 2014-03-28 | 2014-03-25 | 4/A | TRUEX PAUL F | ANTH | Common Stock | D | 3,3000 | −1 352 | −4 | 11 845 | ||||
| 2014-03-28 | 2014-03-25 | 4/A | TRUEX PAUL F | ANTH | Common Stock | D | 3 864 | 13 197 | ||||||
| 2014-03-28 | 2014-03-25 | 4/A | TRUEX PAUL F | ANTH | Common Stock | D | 3,3000 | −7 622 | −25 | 9 333 | ||||
| 2014-03-28 | 2013-06-30 | 4/A | TRUEX PAUL F By Trust | ANTH | Common Stock | I | 3,3000 | 6 250 | 21 | 80 190 | ||||
| 2014-03-27 | 2014-03-25 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 3,30 | 18 440 | 18 440 | |||||
| 2014-03-27 | 2014-03-25 | 4 | TRUEX PAUL F By Trust | ANTH | Common Stock | I | 3,3000 | 6 250 | 21 | 597 787 | ||||
| 2014-03-27 | 2014-03-25 | 4 | TRUEX PAUL F | ANTH | Common Stock | D | 3 864 | 13 197 | ||||||
| 2014-03-27 | 2014-03-25 | 4 | TRUEX PAUL F | ANTH | Common Stock | D | 3,3000 | −7 622 | −25 | 9 333 | ||||
| 2014-03-27 | 2014-03-25 | 4 | ODINK DEBRA | ANTH | Stock option (right to buy) | D | 3,30 | 10 070 | 10 070 | |||||
| 2014-03-27 | 2014-03-25 | 4 | ODINK DEBRA | ANTH | Common Stock | D | −3 864 | 10 465 | ||||||
| 2014-03-27 | 2014-03-25 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 3,3000 | −2 783 | −9 | 6 601 | ||||
| 2014-03-27 | 2014-03-25 | 4 | Hislop Colin | ANTH | Stock option (right to buy) | D | 3,30 | 12 871 | 12 871 | |||||
| 2014-03-27 | 2014-03-25 | 4 | Hislop Colin | ANTH | Common Stock | D | 3 864 | 24 147 | ||||||
| 2014-03-27 | 2014-03-25 | 4 | Hislop Colin | ANTH | Common Stock | D | −3 323 | 20 283 | ||||||
| 2014-03-27 | 2014-03-25 | 4 | LIU MAY | ANTH | Stock Option (right to buy) | D | 3,30 | 6 745 | 6 745 | |||||
| 2014-03-27 | 2014-03-25 | 4 | LIU MAY | ANTH | Common Stock | D | −3 625 | 7 302 | ||||||
| 2014-03-27 | 2014-03-25 | 4 | LIU MAY | ANTH | Common Stock | D | 3,3000 | −529 | −2 | 3 677 | ||||
| 2013-12-18 | 2013-12-16 | 4 | LIU MAY | ANTH | Stock Option (right to buy) | D | 3,02 | 80 000 | 170 494 | |||||
| 2013-07-02 | 2013-06-30 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 0,4900 | −2 248 | −1 | 75 074 | ||||
| 2013-07-02 | 2013-06-30 | 4 | LIU MAY | ANTH | Common Stock | D | 0,4900 | −675 | −0 | 33 655 | ||||
| 2013-06-26 | 2013-06-24 | 4 | Thompson David E. By David E. Thompson Revocable Trust | ANTH | Common Stock | I | 0,5300 | 100 000 | 53 | 128 201 | ||||
| 2013-06-04 | 2013-05-31 | 4 | DZIURZYNSKI BOGDAN | ANTH | Common Stock | D | 0,5900 | 10 000 | 6 | 10 000 | ||||
| 2013-05-28 | 3 | LIU MAY | ANTH | Common Stock | D | 34 330 | ||||||||
| 2013-05-21 | 2013-05-17 | 4 | Hislop Colin | ANTH | Stock option (right to buy) | D | 0,61 | 1 300 000 | 1 300 000 | |||||
| 2013-05-21 | 2013-05-17 | 4 | ODINK DEBRA | ANTH | Stock option (right to buy) | D | 0,61 | 1 400 000 | 1 400 000 | |||||
| 2013-05-21 | 2013-05-21 | 4 | TRUEX PAUL F By Trust | ANTH | Common Stock | I | −100 000 | 591 537 | ||||||
| 2013-05-21 | 2013-05-17 | 4 | TRUEX PAUL F | ANTH | Stock option (right to buy) | D | 0,61 | 5 400 000 | 5 400 000 | |||||
| 2013-05-21 | 2013-05-17 | 4 | LOWE CHRISTOPHER P. | ANTH | Stock option (right to buy) | D | 0,61 | 1 300 000 | 1 300 000 | |||||
| 2013-05-20 | 2013-05-17 | 4 | DZIURZYNSKI BOGDAN | ANTH | Stock Option (right to buy) | D | 0,61 | 100 000 | 100 000 | |||||
| 2013-05-20 | 2013-05-17 | 4 | SPIEGELMAN DANIEL K | ANTH | Stock Option (right to buy) | D | 0,61 | 100 000 | 100 000 | |||||
| 2013-05-20 | 2013-05-17 | 4 | ZWEIFACH SANFORD S | ANTH | Stock Option (right to buy) | D | 0,61 | 150 000 | 150 000 | |||||
| 2013-05-20 | 2013-05-17 | 4 | ZWEIFACH SANFORD S | ANTH | Stock Option (right to buy) | D | 0,61 | 100 000 | 100 000 | |||||
| 2013-05-20 | 2013-05-17 | 4 | HEALY JAMES | ANTH | Stock Option (right to buy) | D | 0,61 | 100 000 | 100 000 | |||||
| 2013-05-20 | 2013-05-17 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 0,61 | 125 000 | 125 000 | |||||
| 2013-05-20 | 2013-05-17 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 0,61 | 100 000 | 100 000 | |||||
| 2013-05-20 | 2013-05-17 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 0,61 | 100 000 | 100 000 | |||||
| 2013-03-27 | 2013-03-25 | 4 | Hislop Colin | ANTH | Common Stock | D | 59 132 | 144 091 | ||||||
| 2013-03-27 | 2013-03-25 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 49 519 | 77 322 | ||||||
| 2013-03-27 | 2013-03-25 | 4 | TRUEX PAUL F | ANTH | Common Stock | D | 135 644 | 135 644 | ||||||
| 2013-03-27 | 2013-03-25 | 4 | LOWE CHRISTOPHER P. | ANTH | Common Stock | D | 67 579 | 108 915 | ||||||
| 2013-02-01 | 2013-01-30 | 4 | ORBIMED ADVISORS LLC See Footnotes | ANTH | Common Stock | I | 0,6600 | 5 700 000 | 3 762 | 7 462 000 | ||||
| 2013-01-29 | 2013-01-25 | 4 | ORBIMED ADVISORS LLC See Footnotes | ANTH | Common Stock | I | 0,6484 | 1 762 000 | 1 142 | 1 762 000 | ||||
| 2013-01-11 | 2013-01-10 | 4 | ODINK DEBRA By The Debra A. Odink Living Trust | ANTH | Common Stock | I | 4 009 | 99 937 | ||||||
| 2013-01-11 | 2013-01-10 | 4 | ODINK DEBRA | ANTH | Common Stock | D | −4 009 | 27 803 | ||||||
| 2013-01-08 | 2013-01-07 | 4 | TRUEX PAUL F By Trust | ANTH | Common stock | I | 66 412 | 691 537 | ||||||
| 2013-01-08 | 2013-01-07 | 4 | TRUEX PAUL F | ANTH | Common Stock | D | −66 412 | 0 | ||||||
| 2013-01-08 | 2013-01-03 | 4 | TRUEX PAUL F | ANTH | Common Stock | D | 0,6900 | −17 454 | −12 | 66 412 | ||||
| 2013-01-07 | 2013-01-03 | 4 | KILFOIL GEORGINA | ANTH | Common Stock | D | 0,6900 | −2 410 | −2 | 30 035 | ||||
| 2013-01-07 | 2013-01-03 | 4 | Hislop Colin | ANTH | Common Stock | D | 0,6900 | −4 560 | −3 | 84 959 | ||||
| 2013-01-07 | 2013-01-03 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 0,6900 | −3 409 | −2 | 31 812 | ||||
| 2013-01-07 | 2013-01-03 | 4 | LOWE CHRISTOPHER P. | ANTH | Common stock | D | 0,6900 | −8 660 | −6 | 41 336 | ||||
| 2012-07-03 | 2012-06-30 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 0,6900 | −1 838 | −1 | 24 821 | ||||
| 2012-07-03 | 2012-06-30 | 4 | KILFOIL GEORGINA | ANTH | Common Stock | D | 0,6900 | −2 068 | −1 | 24 601 | ||||
| 2012-07-03 | 2012-06-29 | 4 | ORBIMED ADVISORS LLC See Footnotes | ANTH | Common Stock | I | 0,7341 | −1 283 300 | −942 | 0 | ||||
| 2012-07-02 | 2012-06-29 | 4 | TRUEX PAUL F By Trust | ANTH | Common stock | I | 0,7600 | 20 000 | 15 | 645 125 | ||||
| 2012-07-02 | 2012-06-29 | 4 | HENNEY CHRISTOPHER S By Christopher Scot Henney TTEE Henney QPRT Maui Trust | ANTH | Common Stock | I | 0,7493 | 100 000 | 75 | 100 000 | ||||
| 2012-07-02 | 2012-06-29 | 4 | HENNEY CHRISTOPHER S | ANTH | Common Stock | D | 0,7493 | 100 000 | 75 | 100 000 | ||||
| 2012-05-10 | 2012-05-08 | 4 | HENNEY CHRISTOPHER S | ANTH | Stock Option (right to buy) | D | 1,79 | 15 000 | 15 000 | |||||
| 2012-05-10 | 2012-05-08 | 4 | DZIURZYNSKI BOGDAN | ANTH | Stock Option (right to buy) | D | 1,79 | 12 000 | 12 000 | |||||
| 2012-05-10 | 2012-05-08 | 4 | HEALY JAMES | ANTH | Stock Option (right to buy) | D | 1,79 | 12 000 | 12 000 | |||||
| 2012-05-10 | 2012-05-08 | 4 | SPIEGELMAN DANIEL K | ANTH | Stock Option (right to buy) | D | 1,79 | 12 000 | 12 000 | |||||
| 2012-05-10 | 2012-05-08 | 4 | Thompson Peter A. | ANTH | Stock Option (right to buy) | D | 1,79 | 12 000 | 12 000 | |||||
| 2012-05-10 | 2012-05-08 | 4 | Thompson David E. | ANTH | Stock Option (right to buy) | D | 1,79 | 12 000 | 12 000 | |||||
| 2012-04-03 | 2012-03-30 | 4 | Hislop Colin | ANTH | Stock Option (right to buy) | D | 2,21 | 80 000 | 80 000 | |||||
| 2012-04-03 | 2012-03-30 | 4 | ODINK DEBRA | ANTH | Stock Option (right to buy) | D | 2,21 | 160 000 | 160 000 | |||||
| 2012-04-03 | 2012-03-30 | 4 | KILFOIL GEORGINA | ANTH | Stock Option (right to buy) | D | 2,21 | 60 000 | 60 000 | |||||
| 2012-04-03 | 2012-03-30 | 4 | DZIURZYNSKI BOGDAN | ANTH | Stock Option (right to buy) | D | 2,21 | 25 000 | 25 000 | |||||
| 2012-04-03 | 2012-03-30 | 4 | TRUEX PAUL F | ANTH | Stock Option (right to buy) | D | 2,21 | 175 000 | 175 000 | |||||
| 2012-04-03 | 2012-03-30 | 4 | LOWE CHRISTOPHER P. | ANTH | Stock Option (right to buy) | D | 2,21 | 80 000 | 80 000 | |||||
| 2012-03-22 | 2012-03-22 | 4 | ORBIMED ADVISORS LLC See Footnotes | ANTH | Common Stock | I | 2,4031 | −1 306 700 | −3 140 | 1 283 300 | ||||
| 2012-03-22 | 2012-03-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | ANTH | Common Stock | I | 2,8665 | −125 000 | −358 | 2 590 000 | ||||
| 2012-03-22 | 2012-03-20 | 4 | ORBIMED ADVISORS LLC See Footnotes | ANTH | Common Stock | I | 2,8993 | −116 800 | −339 | 2 715 000 | ||||
| 2012-03-05 | 2012-03-01 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 6,5700 | −2 000 | −13 | 26 659 | ||||
| 2012-02-27 | 2012-02-23 | 4 | Hislop Colin | ANTH | Stock Option | D | 0,26 | −40 000 | 50 447 | |||||
| 2012-02-27 | 2012-02-23 | 4 | Hislop Colin | ANTH | Common Stock | D | 0,2600 | 40 000 | 10 | 79 519 | ||||
| 2012-02-17 | 2012-02-15 | 4 | TRUEX PAUL F By Trust | ANTH | Common stock | I | 7,8400 | −15 000 | −118 | 625 125 | ||||
| 2012-02-07 | 2012-02-06 | 4 | KILFOIL GEORGINA | ANTH | Common Stock | D | 5 243 | 24 513 | ||||||
| 2012-02-06 | 2012-02-06 | 4 | Hislop Colin | ANTH | Common Stock | D | 9 923 | 39 519 | ||||||
| 2012-02-06 | 2012-02-03 | 4 | Hislop Colin | ANTH | Common Stock | D | 8,2000 | −30 000 | −246 | 27 967 | ||||
| 2012-02-06 | 2012-02-06 | 4 | TRUEX PAUL F | ANTH | Common stock | D | 37 984 | 79 755 | ||||||
| 2012-02-06 | 2012-02-06 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 7 418 | 28 659 | ||||||
| 2012-02-06 | 2012-02-06 | 4 | LOWE CHRISTOPHER P. | ANTH | Common Stock | D | 18 845 | 49 996 | ||||||
| 2012-02-03 | 2012-02-01 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 7,6700 | −2 000 | −15 | 21 241 | ||||
| 2012-02-03 | 2012-02-01 | 4 | LOWE CHRISTOPHER P. | ANTH | Common stock | D | 7,6600 | −15 000 | −115 | 31 151 | ||||
| 2012-02-02 | 2012-01-31 | 4 | TRUEX PAUL F By Trust | ANTH | Common stock | I | 0,2600 | 20 000 | 5 | 640 125 | ||||
| 2012-02-02 | 2012-01-27 | 4 | TRUEX PAUL F By Trust | ANTH | Common stock | I | −7 000 | 620 125 | ||||||
| 2012-02-02 | 2011-01-31 | 4 | TRUEX PAUL F | ANTH | Stock Option (right to buy) | D | 0,26 | −20 000 | 262 826 | |||||
| 2012-01-31 | 2012-01-28 | 4 | HEALY JAMES | ANTH | Stock Option (right to buy) | D | 4,19 | −12 000 | 0 | |||||
| 2012-01-31 | 2012-01-28 | 4 | HEALY JAMES | ANTH | Common Stock | D | 4,1900 | −12 000 | −50 | 32 443 | ||||
| 2012-01-19 | 2012-01-17 | 4 | TRUEX PAUL F By Trust | ANTH | Common stock | I | 6,7500 | −15 000 | −101 | 627 125 | ||||
| 2012-01-12 | 2012-01-10 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 6,5066 | −800 | −5 | 23 241 | ||||
| 2012-01-10 | 2012-01-06 | 4 | ODINK DEBRA | ANTH | Common Stock | D | 6,5000 | −1 200 | −8 | 24 441 | ||||
| 2012-01-03 | 2011-12-30 | 4 | HEALY JAMES See footnote. | ANTH | Common Stock | I | 6,2250 | −280 | −2 | 44 969 | ||||
| 2012-01-03 | 2011-12-30 | 4 | HEALY JAMES See footnote. | ANTH | Common Stock | I | 6,2250 | −4 090 | −25 | 653 550 | ||||
| 2012-01-03 | 2011-12-30 | 4 | HEALY JAMES See footnote. | ANTH | Common Stock | I | 6,2250 | −20 630 | −128 | 3 298 684 | ||||
| 2012-01-03 | 2011-12-30 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | ANTH | Common Stock | D | 6,2250 | −280 | −2 | 44 969 | ||||
| 2012-01-03 | 2011-12-30 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | ANTH | Common Stock | D | 6,2250 | −4 090 | −25 | 653 550 | ||||
| 2012-01-03 | 2011-12-30 | 4 | SOFINNOVA VENTURE PARTNERS VI L P | ANTH | Common Stock | D | 6,2250 | −20 630 | −128 | 3 298 684 | ||||
| 2010-03-26 | 3 | KILFOIL GEORGINA By husband | ANTH | Common Stock | I | 70 093 | ||||||||
| 2010-02-23 | 3 | PENNINGTON JAMES E | ANTH | Common Stock | D | 105 140 | ||||||||
| 2010-02-23 | 3 | ODINK DEBRA By The Debra A. Odink Living Trust | ANTH | Common Stock | I | 78 405 | ||||||||
| 2010-02-23 | 3 | Hislop Colin | ANTH | Common Stock | D | 5 841 | ||||||||
| 2010-02-23 | 3 | Thompson David E. | ANTH | Common Stock | D | 20 443 | ||||||||
| 2010-02-23 | 3 | HENNEY CHRISTOPHER S | ANTH | Common Stock | D | 14 602 | ||||||||
| 2010-02-23 | 3 | Trias Joaquim | ANTH | Common Stock | D | 156 643 | ||||||||
| 2010-02-23 | 3 | TRUEX PAUL F | ANTH | Common Stock | D | 662 967 | ||||||||
| 2010-02-23 | 3 | Fritsch Ursula | ANTH | Common Stock | D | 55 592 | ||||||||
| 2010-02-23 | 3 | HEALY JAMES | ANTH | Common Stock | D | 20 443 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
